Literature DB >> 1402403

Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes.

H Gylling1, T A Miettinen.   

Abstract

The aim of the present study was, first, to investigate whether cholesterol (C) absorption, enhanced by cholesterol feeding, was related to synthesis of cholesterol, serum level of low density lipoprotein (LDL)-C, and receptor activity for LDL apolipoprotein (apo) B in healthy men. Secondly, we were interested in whether apolipoprotein E (apoE) phenotypes contributed to cholesterol and LDL apoB metabolism under these conditions. We studied 29 home-living men aged 55 +/- 1 (mean +/- SE) years on a low-fat, low cholesterol (208 +/- 13 mg/day) diet followed by a low-fat high cholesterol (878 +/- 38 mg/day) diet during 5 weeks. Cholesterol feeding increased total cholesterol, LDL-C, high density lipoprotein (HDL)-C, and LDL apoB levels from 10% to 13% (P less than 0.05) and bile acid production and cholesterol turnover by 16% (P less than 0.05), decreased the fractional catabolic rate (FCR) for LDL apoB by 10% (P less than 0.05) and cholesterol absorption efficiency by 8% (P less than 0.05), while cholesterol synthesis only tended to decrease. During the cholesterol feeding, LDL-C was positively related to apoB production rate and cholesterol absorption efficiency (P less than 0.05), and negatively related to bile acid and cholesterol synthesis (P less than 0.05) and FCR for LDL apoB, which, in turn, was negatively related to cholesterol absorption efficiency and positively to bile acid synthesis. ApoE phenotype was positively related to TC, LDL-C, and LDL apoB levels and negatively to FCR for LDL apoB. The increase of the LDL-C level by the high cholesterol intake was positively correlated with LDL-C on high cholesterol diet and apoE phenotypes, so that the increase was 7% in apoE2 (ns), 11% in apoE3 (P less than 0.05), and 18% in apoE4 (P less than 0.05); the increase of bile acid synthesis was significant only in subjects with apoE2. Moreover, the increase of LDL-C was positively related to the absolute amount of dietary cholesterol absorbed and negatively to FCR for LDL apoB. The findings suggest that the higher the LDL-C level, the higher is the absorption efficiency of cholesterol and production of LDL apoB, and the lower is the removal of LDL apoB and synthesis of both bile acids and cholesterol, and the more frequently the subjects had epsilon 4 allele. The nonresponsiveness to dietary cholesterol was dependent on low LDL-C level, apoE2 phenotype, and effective bile acid synthesis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402403

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans.

Authors:  Niek C A van de Pas; Ruud A Woutersen; Ben van Ommen; Ivonne M C M Rietjens; Albert A de Graaf
Journal:  J Lipid Res       Date:  2012-09-29       Impact factor: 5.922

2.  Plasma noncholesterol sterols as indicators of cholesterol absorption.

Authors:  Scott M Grundy
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

3.  Macronutrient intake modulates impact of EcoRI polymorphism of ApoB gene on lipid profile and inflammatory markers in patients with type 2 diabetes.

Authors:  Faezeh Abaj; Fariba Koohdani
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

4.  Decreased plasma cholesterol concentrations after PUFA-rich diets are not due to reduced cholesterol absorption/synthesis.

Authors:  Vanu R Ramprasath; Peter J H Jones; Donna D Buckley; Laura A Woollett; James E Heubi
Journal:  Lipids       Date:  2012-09-11       Impact factor: 1.880

5.  Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects.

Authors:  W C Duane
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Effect of a synthetic prostaglandin E2 analogue, RS-86505-007, on plasma lipids and lipoproteins in patients with moderate hypercholesterolaemia: efficacy and tolerance of treatment and response in different apolipoprotein polymorphism groups.

Authors:  T Korhonen; M J Savolainen; T Jääskeläinen; Y A Kesäniemi
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease.

Authors:  Helena Gylling; Tatu A Miettinen
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

Review 8.  Computationally Modeling Lipid Metabolism and Aging: A Mini-review.

Authors:  Mark T Mc Auley; Kathleen M Mooney
Journal:  Comput Struct Biotechnol J       Date:  2014-11-15       Impact factor: 7.271

9.  Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors.

Authors:  Israa M Shatwan; Kristian Hillert Winther; Basma Ellahi; Peter Elwood; Yoav Ben-Shlomo; Ian Givens; Margaret P Rayman; Julie A Lovegrove; Karani S Vimaleswaran
Journal:  Lipids Health Dis       Date:  2018-04-30       Impact factor: 3.876

Review 10.  Lowering Low-Density Lipoprotein Cholesterol Concentration with Plant Stanol Esters to Reduce the Risk of Atherosclerotic Cardiovascular Disease Events at a Population Level: A Critical Discussion.

Authors:  Helena Gylling; Timo E Strandberg; Petri T Kovanen; Piia Simonen
Journal:  Nutrients       Date:  2020-08-06       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.